Resting-State Functional MRI and Clinical Outcomes After Acute Disorders of Consciousness: A Systematic Review.

NeurologyOct 29, 2026 (epub)

Karnig Kazazian, Danelle Czink, Alla Iansavitchene et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review examined whether resting-state functional MRI (rs-fMRI) measures during the acute phase of severe brain injury are associated with outcomes in adults with disorders of consciousness. Thirty studies involving 800 patients scanned within 28 days of injury were included; imaging occurred a weighted average of 9.31 days after intensive care unit admission. Across studies, rs-fMRI measures were consistently associated with neurologic or functional outcomes, most often assessed at discharge or 3–12 months after injury. The findings suggest potential prognostic value, but do not establish that rs-fMRI improves prediction or clinical decisions.

Key findings

  • Thirty eligible studies included 800 adults with acute disorders of consciousness; mean age was 48 years and 69% were male.
  • Patients were scanned a weighted average of 9.31 days after intensive care unit admission.
  • Studies consistently reported associations between rs-fMRI measures and neurologic or functional outcomes, despite methodological heterogeneity.
  • The default mode network was assessed most often (n = 20), followed by executive control networks (n = 11).

Why it matters

Prognostication after severe brain injury is challenging, and rs-fMRI offers a way to assess large-scale network integrity without external stimulation. The consistent associations reported across studies support further evaluation of this approach as a potential source of prognostic information. However, association alone does not show that imaging improves outcome prediction or patient management.

What to keep in mind

The review reports substantial heterogeneity and small sample sizes across studies, limiting comparability. Larger prospective studies and standardized acquisition and analysis are needed.

Source

Published in Neurology. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.